This is a medicine used to treat certain types of arthritis, like rheumatoid arthritis. It works by stopping the body from making certain chemicals that cause inflammation. It's a prescription drug.
Every report comes from a Lived member, sent anonymously.
Have you tried Leflunomide for Rheumatoid Arthritis?
Leflunomide, sold under the brand name Arava and as a generic, is a prescription tablet for adults with active rheumatoid arthritis, an autoimmune disease in which the immune system attacks the lining of the joints. It belongs to a group called disease-modifying antirheumatic drugs, or DMARDs. Unlike pain relievers, which ease symptoms for a few hours, DMARDs calm the underlying disease, reducing joint pain, swelling and stiffness and slowing the joint damage that shows up on X-rays. In US guidelines, methotrexate is usually the first DMARD tried for rheumatoid arthritis. Leflunomide is a common alternative when methotrexate isn't suitable or isn't tolerated, and it is sometimes combined with other arthritis medicines. Rheumatologists also prescribe it off-label for psoriatic arthritis, where a placebo-controlled trial found that it improved joint symptoms.
In rheumatoid arthritis, immune cells called lymphocytes multiply and drive inflammation in the joints. To multiply, a cell has to copy its DNA, and that requires a steady supply of building blocks called pyrimidines. Leflunomide blocks an enzyme that cells use to make pyrimidines. Activated lymphocytes need far more of these building blocks than most other cells, so they are especially affected, and the immune attack on the joints quiets down. The body converts leflunomide into its active form, teriflunomide. Teriflunomide is cleared very slowly, which explains several practical features of the drug: why a loading dose is sometimes used, why benefits build over weeks, and why it can stay in the body long after the last tablet.
Leflunomide is a tablet taken once a day, with or without food. The usual dose is 20 mg daily. Some people start with a higher loading dose for the first three days so that the drug reaches a steady level faster; without it, that takes about two months. People at higher risk of liver or blood count problems, including those also taking methotrexate or other immune-suppressing medicines, usually start at 20 mg without the loading dose. If 20 mg causes side effects, the prescriber may lower it to 10 mg. Before the first dose, the care team checks for tuberculosis (TB), measures liver function and blood counts, checks blood pressure and, for anyone who could become pregnant, does a pregnancy test. Stopping leflunomide is different from stopping most medicines. Without help, the active form can take up to two years to leave the body. A washout, usually cholestyramine (a powder that binds the drug in the gut) taken three times a day for 11 days, clears it much faster. It is used before a planned pregnancy, after a serious side effect, or when switching treatments, followed by blood tests to confirm the level is low enough.
Diarrhea is the most common side effect. Nausea, headache, rash, thinning hair and raised liver enzymes on blood tests are also common, and blood pressure can rise. Many of these are mild, but persistent diarrhea or noticeable hair loss is worth raising with the prescriber, as a lower dose may help. Leflunomide carries an FDA boxed warning, the agency's strongest, for severe liver injury, including rare cases of fatal liver failure. Contact the care team promptly for yellowing of the skin or eyes, dark urine, unusual tiredness or pain in the upper abdomen. Because it dampens the immune system, leflunomide can make infections more likely and occasionally lowers blood cell counts. Report fever, repeated infections, easy bruising or bleeding, or unusual paleness promptly. Other serious reactions are rare but need quick attention. A new rash, sores in the mouth or skin ulcers can signal a severe skin reaction. A new or worsening cough or shortness of breath can signal lung inflammation. Numbness, tingling or burning in the hands or feet can signal nerve damage, which is more likely in people over 60 or with diabetes. If a serious reaction occurs, the prescriber usually stops leflunomide and starts a washout.
Leflunomide can cause serious birth defects, a risk covered by its boxed warning. It must not be taken during pregnancy, and anyone who could become pregnant needs a negative pregnancy test before starting and reliable contraception throughout treatment. Because the drug lingers, contraception must continue after stopping until blood tests confirm a very low level. Contact the prescriber right away if a period is missed or pregnancy is suspected, so the drug can be stopped and a washout started. People who want to become pregnant should plan with their rheumatologist well ahead. For men who want to father a child, the label advises stopping leflunomide and completing a washout or confirming a low level first. Some rheumatology guidelines consider continuing acceptable, because the limited data so far show no harm to babies, so this is a decision to make with the rheumatologist. Breastfeeding is not recommended during treatment. Leflunomide is not used in people with significant liver disease, and the risk of liver injury is higher when it is combined with other medicines that strain the liver, including methotrexate. For the same reason, tell the prescriber about any past or current heavy drinking and ask how much alcohol, if any, is safe. It should never be taken together with teriflunomide (Aubagio), a multiple sclerosis medicine that is the same active substance. Leflunomide affects how the body handles several other drugs. People taking warfarin, a blood thinner, need closer INR (international normalized ratio) clotting tests, and the dose of rosuvastatin (Crestor), a cholesterol medicine, should not exceed 10 mg a day. It can also raise hormone levels from some birth control pills, so the type of contraception is worth reviewing. Live vaccines, which contain a weakened form of a virus or bacterium, are not recommended during treatment, and because the drug lingers, timing still matters after stopping. It helps to review vaccinations with the care team before starting.
In clinical trials, improvement in joint pain and swelling was often noticeable within the first month and reached its full level by three to six months. Not everyone responds: in those trials, roughly half of people met a standard measure of meaningful improvement. If the response is not enough after a few months, the rheumatologist may add or switch to another treatment. Regular blood tests are a routine part of taking leflunomide. Liver tests and blood counts are usually checked monthly for the first six months, then every six to eight weeks, and more often when it is combined with methotrexate or similar drugs. Blood pressure is also checked periodically. Rheumatoid arthritis is a long-term condition, so people who do well on leflunomide often take it for years. Stopping it usually allows inflammation to return, so changes are planned with the rheumatologist, along with whether a washout is needed.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Leflunomide, what you've noticed, or ask the community a question.